HEMORGANICTrading & Distributors
Hemo Organic Ltd — Profit & Loss Statement
₹11.70
-1.99%
Hemo Organic Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Tax Rate For Calcs | 0.30 | 0.00 | 0.00 | 0.00 | — |
| Normalized EBITDA | 0.03 Cr | -0.25 Cr | -0.05 Cr | -0.06 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Reconciled Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Reconciled Cost Of Revenue | 2.20 Cr | 0.02 Cr | 16000.00 | 93210.00 | — |
| EBITDA | 0.03 Cr | -0.25 Cr | -0.05 Cr | -0.06 Cr | — |
| EBIT | 0.03 Cr | -0.25 Cr | -0.05 Cr | -0.06 Cr | — |
| Net Interest Income | 0.00 | -0.02 Cr | -1000.00 | -1690.00 | — |
| Interest Expense | 0.00 | 0.02 Cr | 0.00 | 1040.00 | — |
| Normalized Income | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Total Expenses | 2.46 Cr | 0.27 Cr | 0.06 Cr | 0.07 Cr | — |
| Diluted NI Availto Com Stockholders | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Net Income Common Stockholders | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Net Income Including Noncontrolling Interests | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Net Income Continuous Operations | 0.16 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Tax Provision | -0.14 Cr | 0.00 | 0.00 | 0.00 | — |
| Pretax Income | 0.03 Cr | -0.26 Cr | -0.05 Cr | -0.06 Cr | — |
| Other Non Operating Income Expenses | 0.07 Cr | 2000.00 | — | — | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | 0.00 | -0.02 Cr | -1000.00 | -1690.00 | — |
| Interest Expense Non Operating | 0.00 | 0.02 Cr | 0.00 | 1040.00 | — |
| Operating Income | -0.04 Cr | -0.25 Cr | -0.05 Cr | -0.06 Cr | — |
| Operating Expense | 0.26 Cr | 0.25 Cr | 0.06 Cr | 0.06 Cr | — |
| Other Operating Expenses | 0.23 Cr | 0.21 Cr | 0.06 Cr | 0.02 Cr | — |
| Depreciation And Amortization In Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation Income Statement | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Gross Profit | 0.21 Cr | 71000.00 | 32000.00 | -24910.00 | — |
| Cost Of Revenue | 2.20 Cr | 0.02 Cr | 16000.00 | 93210.00 | — |
| Total Revenue | 2.41 Cr | 0.02 Cr | 48000.00 | 68300.00 | — |
| Operating Revenue | 2.41 Cr | 0.02 Cr | 48000.00 | 68300.00 | — |
| Diluted Average Shares | — | 0.35 Cr | 0.35 Cr | 0.35 Cr | 0.35 Cr |
| Basic Average Shares | — | 0.35 Cr | 0.35 Cr | 0.35 Cr | 0.35 Cr |
| Diluted EPS | — | -0.76 | -0.16 | -0.18 | -0.14 |
| Basic EPS | — | -0.76 | -0.16 | -0.18 | -0.14 |
| Total Other Finance Cost | — | 1000.00 | 1000.00 | 650.00 | 1250.00 |
| Selling General And Administration | — | 0.20 Cr | 0.06 Cr | 0.02 Cr | 0.01 Cr |
| Selling And Marketing Expense | — | 2000.00 | 0.00 | 0.00 | 6800.00 |
| General And Administrative Expense | — | 0.20 Cr | 0.06 Cr | 0.02 Cr | 0.01 Cr |
| Write Off | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Hemo Organic Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.